Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sigma Healthcare Ltd ( (AU:SIG) ) just unveiled an update.
Sigma Healthcare has disclosed a change in the equity interests of its director and chief executive, Vikesh Ramsunder, following the allocation of new performance rights under its long-term incentive framework. The grant, made for nil consideration as part of the company’s 2025 Long Term Incentive Plan approved at the 2025 AGM, adds 813,449 rights to acquire fully paid ordinary shares to Ramsunder’s existing holdings, underscoring Sigma’s continued use of equity-based remuneration to align executive incentives with shareholder value and long-term performance.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.39 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Average Trading Volume: 15,600,081
Technical Sentiment Signal: Buy
Current Market Cap: A$33.53B
Find detailed analytics on SIG stock on TipRanks’ Stock Analysis page.